Provided by Tiger Trade Technology Pte. Ltd.

Biomerica

1.75
0.0000
Post-market: 1.72-0.0300-1.71%19:38 EDT
Volume:10K
Turnover:17.22K
Market Cap:5.41M
PE:-1.13
High:1.78
Open:1.78
Low:1.73
Close:1.75
52wk High:4.60
52wk Low:1.73
Shares:3.09M
Float Shares:2.77M
Volume Ratio:0.45
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5513
EPS(LYR):-2.1649
ROE:-94.32%
ROA:-54.58%
PB:1.63
PE(LYR):-0.81

Loading ...

Biomerica receives MHRA registration for hp+detect

TIPRANKS
·
Mar 05

BRIEF-Biomerica Receives Mhra Registration For Hp+Detect™, Allowing Commercial Sales In Great Britain

Reuters
·
Mar 05

Biomerica Secures MHRA Registration for hp+detect in Great Britain

Reuters
·
Mar 05

Biomerica Receives Mhra Registration for HP+Detect™, Allowing Commercial Sales in Great Britain

THOMSON REUTERS
·
Mar 05

Biomerica Inc. Publishes Investor Presentation on inFoods IBS Precision Nutrition Test and GI Diagnostics Pipeline

Reuters
·
Mar 03

Biomerica Reports inFoods IBS Real-World Data Showing 59% Pain Reduction Responders and 68% Bloating Reduction Responders

Reuters
·
Feb 26

Biomerica Reports Real-World Data: Nearly 60% of Ibs Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction With the Infoods® Ibs Therapy

THOMSON REUTERS
·
Feb 26

Vietnam's Hanoi Department of Health approves Biomerica's EZ Detect for nationwide distribution

Reuters
·
Feb 18

Vietnam Approves Biomerica’s Ez Detect™ for Nationwide Distribution

THOMSON REUTERS
·
Feb 18

Medical diagnostics firm Biomerica's Q2 revenue falls amid product transition

Reuters
·
Jan 15

Biomerica Q2 EPS $(0.45) Up From $(0.48) YoY, Sales $1.210M Down From $1.636M YoY

Benzinga
·
Jan 15

BRIEF-Biomerica Q2 Net Income USD -1.32 Million

Reuters
·
Jan 15

Biomerica Inc. cuts research and development expenses by 27% to USD 0.7 million in second quarter (Q2) fiscal 2026

Reuters
·
Jan 15

Biomerica Q2 Revenue USD 1.21 Million

THOMSON REUTERS
·
Jan 15

Biomerica Q2 Gross Margin 4%

THOMSON REUTERS
·
Jan 15

Press Release: Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Dow Jones
·
Jan 15

BRIEF-Biomerica Announces CMS Medicare Payment Rate Of $300 For Revolutionary Infoods® IBS Test

Reuters
·
Dec 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary Infoods® Ibs Test

THOMSON REUTERS
·
Dec 23, 2025

Biomerica Inc - $300 Rate Applies to Medicare Claims From January 2026

THOMSON REUTERS
·
Dec 23, 2025

Biomerica Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 16, 2025